Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07227259 · ClinicalTrials.gov registry record · NA

Health Properties of Pecan Nut Consumption

A NA study of Healthy Adults, sponsored by University of California, Davis.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT07227259: Recruiting NA study of Healthy Adults, sponsored by University of California, Davis.

NCT07227259 is a NA study of Healthy Adults that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 40 participants, below the 85-participant average among 33 other Healthy Adults trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07227259, a NA study of Healthy Adults, is actively recruiting participants, sponsored by University of California, Davis.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The main goal of this clinical study is to see if consuming pecan nuts will result in improvements in overall body metabolism such as in blood lipids, markers of inflammation, blood pressure, cognitive performance and changes in bacteria living in the gut in adults 45 to 75 years of age. Participants will take part in two 3-month intervention periods, separated by 4-6 weeks, in random order ( a total of approximately 7 months). During one intervention period, they will include pecan nuts in their diet each day, while during the other intervention period they will avoid pecans in their diet. There will be an initial screening visit to evaluate eligibility and four study visits to the clinic. Participants will be asked to complete some questionnaires about their diet, physical and cognitive health, and provide blood and stool samples, and have their blood pressure measured.

Primary Outcome

Vascular response as measured by Pulse Wave Velocity (PWV)

Conditions Studied

Interventions

  • OTHER pecan nut

Study Locations (1)

California

  • Ragle Human Nutrition Center, UC Davis campus - Davis

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-11-15
Est. Completion 2027-12
Phase NA
University of California, Davis

657 total trials

What NCT07227259 shows while recruiting

NCT07227259 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 85-participant average among 33 other Healthy Adults trials with a reported enrollment target (53% lower).

The record links to 1 condition, with Healthy Adults appearing as the primary indexed condition, and to 1 intervention - of which pecan nut is the first listed.

NCT07227259 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT07227259 about?

NCT07227259 is a clinical study titled "Health Properties of Pecan Nut Consumption". The main goal of this clinical study is to see if consuming pecan nuts will result in improvements in overall body metabolism such as in blood lipids, markers of inflammation, blood pressure, cognitive performance and changes in bacteria living in the gut in adults 45 to 75 years of age. Participan...

What is the current status of trial NCT07227259?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-11-15. Estimated completion is 2027-12.

What conditions does trial NCT07227259 study?

This clinical trial studies the following conditions: Healthy Adults.

What interventions are being tested in trial NCT07227259?

The interventions under investigation include: pecan nut (OTHER).

Who is sponsoring clinical trial NCT07227259?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07227259 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Adults

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07227259's enrollment target sits among peer trials

40 12th of 33 higher than 19 of 33 other Healthy Adults trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy Adults trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07227259, the US trial registry maintained by the National Library of Medicine. NCT07227259 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.